Campho-Phenique

Quick links to important sections

Campho-Phenique

Method of action: Local Anesthetic

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Campho-Phenique

This foundational section provides a concise overview of the Campho-Phenique preparation, specifically the formulation containing the Pramocaine active ingredient, focusing on its identity, classification, and composition.

Property Description
Active ingredient Pramocaine (Pramoxine)
Form Topical preparation (Cream, Ointment, Lotion)
Pharmacological class Local Anesthetic and Antipruritic
Common purpose Temporary relief of pain and itching
Origin Synthetic (Morpholine derivative)

What Type of Medicine is Campho-Phenique and Pramocaine?

Campho-Phenique is an Over-the-counter medication (Human OTC Drug) classified as a specialized Topical preparation intended for direct application to the skin. Its single key component, the Active ingredient Pramocaine (Pramoxine), is primarily classified as a Local Anesthetic and Antipruritic (anti-itch agent). This dual classification establishes its general purpose: providing temporary relief of pain and temporary relief of itching associated with minor skin irritations such as those from insect bites or cold sores. The preparation is widely recognized for its efficacy in providing targeted, non-systemic relief, making it a reliable choice for managing acute cutaneous discomfort.

Composition and Physical Form of Campho-Phenique

The medicinal action is derived from Pramocaine HCl, a synthetic chemical substance that is a morpholine derivative. Pramoxine is clinically recognized for its ability to relieve localized itching and pain. The product is manufactured for the Topical route of administration and is commonly available in several Drug forms, including a moisturizing Cream and a protective Ointment. The Campho-Phenique brand often utilizes specific formulations where the vehicle, particularly the ointment base, incorporates a Skin protectant like White Petrolatum, which provides a valuable physical barrier against external irritants while supporting the delivery of the active ingredient. This specialized vehicle composition differentiates its application profile.

Key Difference: Local Anesthesia vs. Counterirritation

The product’s therapeutic effect stems from Pramocaine’s ability to achieve a targeted Localized Numbing Effect by directly, and reversibly, interrupting the transmission of sensory signals in the skin’s nerve endings. Pramocaine works by preventing the necessary ionic fluctuations for the nerve impulse to travel, thereby stabilizing the neuronal membrane. This direct blockage of nerve signals is the specific action that provides temporary relief from minor pain and itching. This scientifically supported mechanism distinguishes the preparation’s action from that of older counterirritant agents, which rely on the sensation of cooling or heat to distract the nerves rather than by directly inhibiting the pain signal conduction.

What side effects are possible with Campho-Phenique?

Possible Side Effects and Safety Information

The safety profile of topical Pramocaine (the active ingredient in Campho-Phenique) is characterized by localized reactions, consistent with its classification as a topical local anesthetic in regulatory documents. Adverse effects are primarily categorized under Skin and Subcutaneous Tissue Disorders.


Documented Local and Systemic Adverse Reactions

The most commonly reported effects are localized to the site of application and are generally considered less serious side effects. These include a temporary burning or stinging sensation upon initial use, as well as localized redness, irritation, dryness, and swelling. New or worsened itching is also documented.

Serious adverse reactions are reported rarely, but official labeling highlights the risk of Severe Allergic Reactions, classified under Immune System Disorders. These systemic manifestations of hypersensitivity include signs such as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat. Severe, persistent pain, burning, or swelling at the application site may also be considered clinically significant.


Safety Constraints and Considerations

A known Hypersensitivity to Pramocaine or any component of the formulation is a formal constraint against use. The official safety information restricts application; the product should not be applied to deep skin wounds, blistered skin, severe burns, or large areas of the body.

For specific populations, regulatory data states that the effects of Pramocaine during pregnancy and whether it passes into breast milk are not known, as formal safety studies in these groups are currently lacking. There are no known high-level interactions documented between topical Pramocaine and other medicines.

Overdose and Emergency Response

Overdose and when to seek help — Official Regulatory Information for Campho-Phenique

This section summarizes the official descriptions of overdose manifestations, associated risks, and the required emergency actions as stated in government regulatory documents for Pramocaine-containing products.

Overdose Scope Official Regulatory Statement
Documented Overdose Presentations Accidental ingestion is associated with systemic signs that may include Fever, Nausea, Vomiting, Stomach cramps, and Diarrhoea (typically occurring hours after swallowing).
Serious Outcomes Sufficient systemic absorption of the topical agent may lead to HPA axis suppression and manifestations of Cushing's syndrome. A potential serious outcome following excessive exposure is Methaemoglobinaemia.
Exposure Risks The risk of systemic toxicity is associated with the application of large doses over a large surface area and is noted to be higher in pediatric patients due to their greater proportional absorption.

Required Emergency Actions and Management

  • If the product is swallowed, regulatory labeling mandates that an individual must get medical help or contact a Poison Control Center immediately.
  • Management for acute overdosage may include defined procedures such as Gastric lavage, Purgation with magnesium sulfate, and General supportive measures.
  • For the specific complication of Methaemoglobinaemia, regulatory documents specify treatment with the antidote methylthioninium chloride.
  • Monitoring requirements for systemic effects may include periodic evaluation using the urinary free cortisol and ACTH stimulation tests.

This concise summary is based strictly on the official prescribing and emergency-response sections found in government-authorized documents, defining the necessary actions under specific overdose scenarios.

Therapeutic Uses of Campho-Phenique

What Campho-Phenique Treats: Main Uses and Benefits

The core purpose of Campho-Phenique (Pramocaine) is to provide localized symptomatic support for a focused range of acute, minor irritations. The medication is applied in situations involving certain distressing symptoms related to physical discomfort.

The preparation is commonly used across domains involving minor surface-level skin trauma and everyday irritations. It helps address symptom clusters of localized pain and burning sensations that accompany conditions like small cuts, superficial scrapes, and minor burns, and is considered relevant for discomfort caused by insect bites or contact with poison ivy, poison oak, or poison sumac. The medication may be part of symptomatic management for minor anorectal discomfort, notably the soreness and pain associated with hemorrhoids.

Quick Fact: Relief for Pruritus and Pain

The medication is used for managing symptoms related to inflammatory or irritative states and persistent cutaneous itching and surface pain. When managing these symptoms, it provides supportive relief when symptoms interfere with routine activities and supports general well-being during symptomatic phases.

Eligibility and Restrictions for Use

Who Can and Cannot Use Campho-Phenique?

This section details the officially documented population eligibility and restrictions for using Campho-Phenique (Camphor/Phenol) according to regulatory labeling.

Approved and Restricted Populations

Population Group Regulatory Status
Adults and Children Use Permitted for those 2 years of age and over under standard labeled conditions.
Children under 2 years Use Restricted; consultation with a doctor is required before application.
Pregnant/Breastfeeding Conditional Use; regulatory guidance is to ask a doctor before use.

Absolute Exclusions and Conditional Use

Regulatory documents impose specific restrictions on both application method and injury type. The medication is prohibited (Do Not Use) over large areas of the body or when applied with a bandage or occlusive dressing. It is also contraindicated for individuals with a known allergy to Camphor or Phenol. Conditional use, requiring consultation with a doctor, applies to individuals with a deep or puncture wound, animal bites, or serious burns, as use is not permitted for these conditions without professional advice.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Campho-Phenique (Pramocaine topical) establishes a minimal interaction structure, consistent with a topical medication that demonstrates negligible systemic absorption when used on intact skin. This lack of systemic involvement is the primary finding in regulatory interaction sections.

Lack of Documented Systemic Interactions

Interaction Type Regulatory Finding
Metabolic Interactions No specific interactions involving Cytochrome P450 (CYP) enzymes or drug transporters are documented in the official labeling.
Exposure-Altering Drugs No systemic medicinal products are officially listed as altering the systemic concentration of Pramocaine (AUC or Cmax).
Food, Alcohol, Supplements No known interactions with food, alcohol, or herbal products are formally cited by government authorities.
Timing Rules No mandatory separation windows between administration of this topical product and other medicines are specified.

Pharmacodynamic Constraints

The primary regulatory constraint is a class-based caution regarding the potential for an additive pharmacodynamic effect when co-administered with other local anesthetics or "numbing medicines." This addresses the theoretical risk of combined effects should significant absorption occur, which limits the use of multiple anesthetic products on the same area. The official regulatory documentation does not classify any specific systemic drug combination as formally contraindicated.

Mechanism of Action

Peripheral Somatosensory Modulation

The ingredient camphor interacts with Transient Receptor Potential (TRP) ion channels on peripheral sensory neurons. It acts as an agonist for channels like TRPV1 and TRPV3, initiating a sensory impulse that is immediately followed by rapid desensitization (inactivation) of these channels. This process modulates the nerve's excitability, leading to the interruption of nociceptive and pruriceptive signal transmission, which results in the attenuation of afferent sensory signaling.


Microbial Cell Integrity Disruption

Phenol functions as a non-specific cellular agent that penetrates microbial structures. It causes the denaturation of essential proteins and disrupts the integrity of the cell membranes in bacteria and fungi upon contact. This action impairs cellular metabolism and structure, leading to the localized death and inactivation of microbes.


Cascade of Coordinated Physiological Effects

The overall pharmacodynamic profile is defined by the coordination of these two primary actions. Camphor's counter-irritant mechanism rapidly attenuates sensory nerve activity, while phenol concurrently causes the destruction of surface pathogens. This dual action leads to coordinated peripheral sensory and antimicrobial effects within the affected tissue area.

Dosage and Administration Information

Instruction Map: How to Use Campho-Phenique — Official Administration Guidelines

This map formalizes the instructions for using Campho-Phenique (Pramocaine Hydrochloride 1%), focusing on the standardized protocol for topical analgesics.


Administration Scope

Feature Instruction / Principle
Route of administration Topical (External use only).
Dosing schedule Apply a thin film or sufficient quantity to cover the affected area of the skin.
Age-group administration rules Adults and children 2 years of age and older: Apply up to the maximum frequency limit. – Children under 2 years of age: It is necessary to consult a doctor prior to use.
Special procedural conditions The product must not be applied to the eyes. Use is restricted to the outer surface of the skin.

Instruction Classifications (High-Level)

Classification Principle
Administration method type Topical
Frequency pattern As-needed (PRN), with a strict limit of not more than 3 to 4 times daily.
Standard Classification Topical analgesic for Pramoxine Hydrochloride.
Course duration / cycle information Use is limited; discontinuation is necessary if symptoms persist for more than 7 days.

Resulting Procedural Structure

Official step sequence:

  • Apply the preparation gently onto the targeted area of the skin's surface.
  • Ensure the daily application frequency does not exceed the limit of 4 times per 24 hours.
  • Discontinue use if symptoms do not resolve or if the condition clears up and recurs within a few days.

Connection to the overall use protocol (2–4 sentences):

These instructions establish a precise, non-systemic use protocol for the topical preparation. The constraints define the standardized administration route and set clear limits on frequency and duration, ensuring use remains within established safety and effectiveness parameters. The age-specific rule further restricts unsupervised use to older children and adults.

Recent Clinical Evidence

Research Evidence / Overview of studies for Campho-Phenique

Evidence for Relief of Minor Surface Pain and Skin Irritations

Pramocaine, the active ingredient in Campho-Phenique, was determined to have its regulatory status based on historical clinical data and a review by expert panels. The regulatory status was based on a historical review of clinical data and a review by expert panels. This body of evidence was applied in studies examining patient-reported experiences of outcomes related to physical discomfort associated with conditions involving periods of heightened symptoms, such as small cuts, minor burns, and insect bites. These historical reviews of safety and usage described the substance in research exploring temporary, localized symptom patterns.

The regulatory designation is associated with data reviewed under the monograph process. A key limitation is that the regulatory designation for this broad use is associated with older evidence rather than recent, single-ingredient, Randomized Controlled Trials (RCTs). Therefore, comparative evidence is lacking for the single active ingredient in this area.


Evidence for the Management of Localized Itching (Pruritus)

Research exploring the localized symptom effects of Pramocaine was evaluated in settings of discomfort, including for conditions where symptoms may vary in intensity. Studies designed to explore this effect include Randomized Controlled Trials (RCTs) and open-label pilot studies. These trials primarily studies monitored patient-reported outcomes related to perceived discomfort, specifically quantifying symptom intensity or variability.

These studies conducted during periods of increased symptom activity included adults presenting with various dermatological issues, such as uremic pruritus in dialysis patients, a condition relevant to patients with kidney disease. Follow-up durations sometimes extended up to four weeks in defined study intervals.

Key limitations in this body of research include the fact that sample sizes were modest in the more rigorous RCTs. Furthermore, much of the research was observed in some studies that used Pramocaine in combination with other therapeutic agents, meaning data for certain groups remain limited for the single active ingredient alone.

Key Studies & References Over-the-Counter (OTC) Drug Monograph for Anorectal Drug Products (Pramoxine Hydrochloride 1%)

Frequently Asked Questions (FAQ)

Common questions about Campho-Phenique (FAQ)


Q: What is the significance of Camphor and Phenol being the two main ingredients?

Camphor and Phenol are the Active Ingredients in the product. According to official product information, their combined regulatory purpose is classified as a Pain reliever/antiseptic. This classification indicates the product’s purpose is to offer temporary pain relief and protection against infection.

Q: Is it true that the product was originally intended as a general first aid antiseptic?

Official regulatory documents classify the product by its purpose as a Pain reliever/antiseptic. It is indicated for first aid to help protect against infection in minor cuts, scrapes, and burns, which aligns with the function of a general first aid treatment.

Q: Can Campho-Phenique be used on sunburn?

Official product information explicitly lists sunburn in the Uses section. The product is indicated for the temporary relief of pain and itching associated with sunburn.

Q: Is there any clinical research on Campho-Phenique's effectiveness for cold sores?

Yes, the regulatory documentation lists cold sores in its Uses section. This indicates that the claim for the temporary relief of pain and itching associated with the condition is substantiated for its Over-the-Counter status.

Q: Does Campho-Phenique kill the Herpes Simplex Virus (HSV)?

The product is classified as an Antiseptic and is intended to help protect against infection in minor wounds. This typically means preventing secondary bacterial infection in minor wounds. The product label does not classify it as an antiviral or specify action directly against the Herpes Simplex Virus.

Q: Can Campho-Phenique be applied to a cold sore before it turns into a blister?

The product is indicated for the pain and itching of cold sores, but official warnings strictly restrict use on blistered skin. This constraint suggests the product is for use before the lesion develops into a blister. For any type of severe wound, regulatory guidance states a doctor must be consulted.

Q: Can Campho-Phenique be used on skin that is broken or bleeding?

The product is for external use only. Official warnings specifically advise against using the product on deep or puncture wounds or serious burns. For any type of severe wound, regulatory guidance states a doctor must be consulted.

Q: Is Campho-Phenique effective for canker sores inside the mouth?

No. The product is strictly for external use only and is officially classified as a TOPICAL application for the skin. It is not intended for use on internal mucous membranes, such as those inside the mouth where canker sores occur.

Q: Can I use Campho-Phenique on my lips?

The product is listed for cold sores, which may occur on the lips. However, the product is strictly for external use only, meaning it must not be applied to mucous membranes or accidentally ingested. Care must be taken to ensure it remains on the outer surface.

Q: Can Campho-Phenique be used for relieving pruritus (itching) from chickenpox?

Official warnings state that the product should not be used over large areas of the body. Because conditions like chickenpox often involve widespread lesions, this restriction generally limits its use on widespread skin conditions.

Q: Is there a risk of overdose from using too much Campho-Phenique on the skin?

Yes. Official warnings advise restricting application to not over large areas of the body and using it no more than 3 times daily. The restriction is in place because high use increases the risk of systemic absorption and potential toxicity.

Q: Is it true that camphor, one of the ingredients, can be poisonous in high amounts?

The product contains the active ingredient Camphor, which is known to be toxic if swallowed in significant amounts. The need to contact a Poison Control Center right away if ingestion occurs reflects the known toxicity of high concentrations of camphor.

Q: What is the risk if a small amount of Campho-Phenique is accidentally swallowed?

Official warnings state that if the product is swallowed, you should get medical help or contact a Poison Control Center right away. It is further advised to not induce vomiting before contacting medical assistance or the Poison Control Center.

Q: What should I do if Campho-Phenique gets into my eye?

Official warnings state that the product must not be used in or near the eyes. If contact occurs, the eyes should be rinsed thoroughly with water and medical attention obtained.

Q: Does Campho-Phenique cause skin discoloration or change the color of the affected area?

Information on the active ingredient Phenol indicates that contact can cause temporary whitening of the skin at the application site. This may sometimes be followed by temporary brown staining.

Q: What are the official warnings listed on the Campho-Phenique product packaging?

Key official warnings state that the product is for external use only, should not be used over large areas of the body, and should not be used with a bandage. Additionally, the label advises consulting a doctor before use on animal bites or serious burns.

Q: How do I know if my condition is worsening and I need to stop using the product?

Official warnings advise discontinuing use and asking a doctor if the condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur again within a few days.

Q: Why does Campho-Phenique have a strong smell?

The characteristic odor is due to the ingredients Camphor, Phenol, and Eucalyptus Oil. These components are aromatic and contribute to the product's distinct scent.

Q: Why does Campho-Phenique contain eucalyptus oil?

Eucalyptus Oil is listed as an Inactive Ingredient in the product formulation. Inactive ingredients are typically used to help with the scent, texture, or stability of the final preparation.

Q: Does Campho-Phenique contain any ingredients that could be bad for pets if they came into contact with it?

The active ingredients Camphor and Phenol are known to be toxic to pets if absorbed or ingested. Official product warnings advise storing the product out of the reach of children due to the toxicity of the active ingredients.

How should Campho-Phenique be stored and disposed of?

How to Store and Dispose of Campho-Phenique?

This section outlines the official, label-based requirements for storing and discarding Campho-Phenique (Pramocaine topical preparations).

Storage Requirements

The medication must be stored at controlled room temperature and protected from excessive heat and freezing to maintain its stability. The container must be kept tightly closed and stored in the original container, away from moisture and direct light. As a mandatory regulation for all over-the-counter medicines, it must always be stored out of the reach and sight of children.

Disposal Instructions

Expired or unused Campho-Phenique must be properly discarded according to local guidelines. To prevent environmental contamination, it is strictly advised not to flush the medication down the toilet or pour it into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Campho-Phenique found in:

A-Z Index: